Piperidine Carboxamide Azaindane CGRP Antagonists for Migraine
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current migraine treatments, particularly triptans and preventive drugs, have limited efficacy and significant side effects, and there is a need for safer and more effective CGRP receptor antagonists to manage migraine symptoms and prevent recurrence.
Innovation Solution
Development of substituted piperidinecarboxamide azaindane derivatives that act as CGRP receptor antagonists, represented by specific general formulas, to target and inhibit the activity of calcitonin gene-related peptide, thereby reducing migraine severity and frequency.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If triptans are used for migraine treatment, then migraine symptoms can be relieved, but cardiovascular risks and side effects increase
Solution Approach 1:
The patent modifies the molecular structure of CGRP receptor antagonists by changing chemical parameters (introducing fluorine atoms at specific positions, adjusting side chain lengths and configurations) to optimize the balance between binding affinity and safety profile, thereby maintaining efficacy while reducing cardiovascular risks associated with traditional triptans
2Reliability
If preventive drugs like anti-epileptic drugs and beta-blockers are used, then migraine prevention can be achieved, but side effects and lack of specificity increase
Solution Approach 1:
The patent develops CGRP receptor antagonists with specific local structural features (fluorine substitution at defined positions, particular stereochemical configurations) that provide selective binding to CGRP receptors, thereby achieving migraine prevention through a mechanism specific to migraine pathophysiology rather than using non-specific drugs with broad side effect profiles
3Object-affected harmful factors
If new CGRP receptor antagonist compounds are developed, then treatment safety can be improved, but development complexity and time increase
Solution Approach 1:
The patent employs a systematic approach to drug development by segmenting the molecular structure into key functional regions (core scaffold, side chains, substituent groups) and independently optimizing each region through computer-aided design and iterative synthesis, thereby managing development complexity while improving safety profiles
Data Source
AI summary
The present application relates to a substituted piperidine carboxamide azaindane derivative, a method for preparing same, and use of a pharmaceutical composition containing the derivative or a deuterated derivative in medicine. Specifically, the present application relates to a substituted piperidine carboxamide azaindane derivative represented by general formula (I), a method for preparing same, a pharmaceutically acceptable salt thereof, and use thereof as a CGRP receptor antagonist in preventing and/or treating CORP-related diseases, in particular the field of migraine. The definition of each substituent in general formula (I) is the same as that in the specification.